failure to respond or late response
on 15 Apr 2024
Last Applicant/ Owned by
Tänassilma tee 11
EE
Serial Number
79360915 filed on 08th Dec 2022
Registration Number
N/A
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Antiallergic medicines; pharmaceutical preparations and substances, namely, cardiovascular pharmaceutical preparations; milk ferments for pharmaceutical purposes; antibacterial sprays; flaxseeds for pharmaceutical purposes and natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; anti-viral substances being antivirals;Read More
Antiallergic medicines; pharmaceutical preparations and substances, namely, cardiovascular pharmaceutical preparations; milk ferments for pharmaceutical purposes; antibacterial sprays; flaxseeds for pharmaceutical purposes and natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; anti-viral substances being antivirals; anti-viral agents being antivirals; antiviral prodrugs being antivirals; nasal sprays for medical purposes; medicated nasal spray preparations
No 79360915
No Service/Collective Mark
No
No
No
No
No
Yes
Yes
No
No
03.23.15 -
Micro-organisms (including sperms)
26.11.21 -
Rectangles that are completely or partially shaded
26.15.02 -
Plain single or multiple line polygons
26.15.21 -
Polygons that are completely or partially shaded
Status Date | Action Taken |
---|---|
15th Apr 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
15th Apr 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
24th Oct 2023 | REFUSAL PROCESSED BY IB |
01st Oct 2023 | REFUSAL PROCESSED BY MPU |
01st Oct 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
20th Sep 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
19th Sep 2023 | NON-FINAL ACTION WRITTEN |
14th Sep 2023 | ASSIGNED TO EXAMINER |
31st Jan 2023 | APPLICATION FILING RECEIPT MAILED |
27th Jan 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |